scholarly journals Myocarditis and Drug Rash With Eosinophilia and Systemic Symptoms Syndrome: A Deadly Combination

Cureus ◽  
2021 ◽  
Author(s):  
Angel C De La Cruz ◽  
Shoaib Ashraf ◽  
Nikee Shrestha ◽  
Muhammad Saad
Keyword(s):  
2003 ◽  
Vol 84 (1) ◽  
pp. 92-94 ◽  
Author(s):  
Thierry Passeron ◽  
Mamadou Cissé Ndir ◽  
Cécile Aubron ◽  
Philippe Hovette
Keyword(s):  

2007 ◽  
Vol 24 (6) ◽  
pp. 666-668 ◽  
Author(s):  
SHAKER BEN SALEM ◽  
RAOUDHA SLIM ◽  
MOHAMED DENGUEZLI ◽  
RAFIA NOUIRA ◽  
HOUSSEM HMOUDA ◽  
...  
Keyword(s):  

Author(s):  
SANG-HA KIM ◽  
Shun Nyung Lee ◽  
Seok Jeong Lee ◽  
Myoung Kyu Lee ◽  
Won Yeon Lee ◽  
...  
Keyword(s):  

2009 ◽  
Vol 20 ◽  
pp. S92-S93
Author(s):  
Gulistan Bahat ◽  
Hulya Gamze Celik ◽  
Bulent Saka ◽  
Fatih Tufan ◽  
Cemil Tascioglu
Keyword(s):  

2008 ◽  
Vol 50 (3) ◽  
pp. 406-408 ◽  
Author(s):  
Takehisa Fujiwaki ◽  
Tetsushi Yoshikawa ◽  
Reiko Urashima ◽  
Chihiro Ishioka
Keyword(s):  

2016 ◽  
Vol 3 (3) ◽  
Author(s):  
Rannakoe J. Lehloenya ◽  
Sipho Dlamini ◽  
Rudzani Muloiwa ◽  
Betty Kakande ◽  
Mzudumile R. Ngwanya ◽  
...  

Abstract Elimination of a rifamycin from the treatment regimen for tuberculosis negatively impacts outcomes. Cross-reactivity between the rifamycins after drug eruptions is unclear. We report 6 consecutive human immunodeficiency virus-infected patients with rifampicin-associated drug rash with eosinophilia and systemic symptoms (DRESS) syndrome confirmed on diagnostic rechallenge. The patients subsequently tolerated rifabutin. These data inform clinical management of tuberculosis-associated drug reactions.


Sign in / Sign up

Export Citation Format

Share Document